Insiders · GPCR

Jun Yoon

Chief Financial Officer at Structure Therapeutics Inc. (GPCR)

Jun Yoon has filed 6 insider reports with the SEC since March 2024, as chief Financial Officer at Structure Therapeutics Inc. (GPCR). The latest filing, on March 23, 2026, reports grant or award at Structure Therapeutics Inc. (GPCR).

Filings
6
Companies
1
Bought on market
None
Sold on market
None

Companies where Jun Yoon is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Structure Therapeutics Inc. logo
GPCR
Structure Therapeutics Inc.
Chief Financial Officer1,401,656$17.36Mar 23, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Jun Yoon with

Other insiders at the same companies

Questions about Jun Yoon

What is Jun Yoon's role at Structure Therapeutics Inc.?
Jun Yoon reports to the SEC as chief Financial Officer at Structure Therapeutics Inc. (GPCR), according to the latest filing on March 23, 2026.
How many shares does Jun Yoon own?
After the latest filing that states it, Jun Yoon directly owned 1,401,656 shares of Structure Therapeutics Inc. (GPCR). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Jun Yoon bought or sold stock recently?
No open-market purchases or sales by Jun Yoon are on file. The filings report grant or award and shares withheld for taxes or exercise price.
How do I get alerts when Jun Yoon files?
Follow Jun Yoon on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Jun Yoon (SEC CIK 0001962414). Totals count each trade once, skipping amendments whose original is on file, from Mar 19, 2024 on. View on SEC EDGAR